D Beck

872 total citations
24 papers, 726 citations indexed

About

D Beck is a scholar working on Neurology, Molecular Biology and Immunology. According to data from OpenAlex, D Beck has authored 24 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 11 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in D Beck's work include Neuroblastoma Research and Treatments (20 papers), Signaling Pathways in Disease (4 papers) and Cancer therapeutics and mechanisms (3 papers). D Beck is often cited by papers focused on Neuroblastoma Research and Treatments (20 papers), Signaling Pathways in Disease (4 papers) and Cancer therapeutics and mechanisms (3 papers). D Beck collaborates with scholars based in Switzerland, France and United Kingdom. D Beck's co-authors include Didier Frappaz, M Favrot, Nicole Groß, David G. Jackson, S Carrel, Geneviève Perruisseau, Valérie Combaret, Christine Lasset, Thierry Philip and Angelika Bischof Delaloye and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

D Beck

24 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Beck Switzerland 18 443 323 140 133 106 24 726
Seeger Rc United States 14 606 1.4× 410 1.3× 214 1.5× 108 0.8× 29 0.3× 20 714
R C Seeger United States 11 527 1.2× 266 0.8× 205 1.5× 132 1.0× 26 0.2× 20 659
Nicholas Murray United Kingdom 10 304 0.7× 224 0.7× 53 0.4× 168 1.3× 42 0.4× 19 669
James N. Gerson United States 10 374 0.8× 236 0.7× 98 0.7× 123 0.9× 28 0.3× 16 636
F. Vega France 10 387 0.9× 158 0.5× 44 0.3× 80 0.6× 37 0.3× 14 616
Kathleen Dashner United States 11 199 0.4× 220 0.7× 71 0.5× 118 0.9× 38 0.4× 14 701
J T Kemshead United Kingdom 17 493 1.1× 244 0.8× 170 1.2× 157 1.2× 11 0.1× 36 896
Véronique Laithier France 12 271 0.6× 267 0.8× 138 1.0× 370 2.8× 29 0.3× 27 1.1k
Osarenoma Olomu United States 6 193 0.4× 257 0.8× 74 0.5× 152 1.1× 104 1.0× 17 663
E Hatva Finland 8 106 0.2× 475 1.5× 223 1.6× 162 1.2× 44 0.4× 8 786

Countries citing papers authored by D Beck

Since Specialization
Citations

This map shows the geographic impact of D Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Beck more than expected).

Fields of papers citing papers by D Beck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Beck. The network helps show where D Beck may publish in the future.

Co-authorship network of co-authors of D Beck

This figure shows the co-authorship network connecting the top 25 collaborators of D Beck. A scholar is included among the top collaborators of D Beck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Beck. D Beck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coze, Carole, Olivier Hartmann, Jean Michon, et al.. (1997). NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.. Journal of Clinical Oncology. 15(12). 3433–3440. 51 indexed citations
2.
Combaret, Valérie, Christine Lasset, Didier Frappaz, et al.. (1997). Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma. European Journal of Cancer. 33(12). 2101–2105. 24 indexed citations
3.
Gudinchet, F., et al.. (1997). Evaluating bone marrow metastasis of neuroblastoma with iodine-123-MIBG scintigraphy and MRI.. PubMed. 38(9). 1389–92. 22 indexed citations
4.
Combaret, Valérie, Christine Lasset, Didier Frappaz, et al.. (1996). Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.. Journal of Clinical Oncology. 14(1). 25–34. 76 indexed citations
5.
Beck, D, et al.. (1995). CB44 expression and modulation on human neuroblastoma tumours and cell lines. European Journal of Cancer. 31(4). 471–475. 16 indexed citations
6.
Beck, D, et al.. (1995). Recombinant erythropoietin in acute chemotherapy‐induced anemia of children with cancer. Medical and Pediatric Oncology. 25(1). 17–21. 30 indexed citations
7.
Delaloye, Angelika Bischof, et al.. (1995). Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology. European Journal of Nuclear Medicine and Molecular Imaging. 22(4). 322–329. 37 indexed citations
8.
Miescher, G, et al.. (1994). Altered growth and phenotype in clonal mycN transfectants of the sk‐n‐sh neuroblastoma cell line. International Journal of Cancer. 59(1). 141–148. 21 indexed citations
9.
Jackson, David G., et al.. (1994). CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.. PubMed. 54(15). 4238–42. 73 indexed citations
10.
Philip, Thierry, Ruth Ladenstein, J M Zucker, et al.. (1993). Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study. British Journal of Cancer. 67(1). 119–127. 53 indexed citations
11.
Groß, Nicole, et al.. (1992). Differentiation‐related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants. International Journal of Cancer. 52(1). 85–91. 42 indexed citations
12.
Beck, D, et al.. (1991). Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia. Medical and Pediatric Oncology. 19(3). 192–198. 23 indexed citations
13.
Beck, D, et al.. (1991). Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity. European Journal of Pediatrics. 150(11). 767–772. 40 indexed citations
14.
Carrel, S, et al.. (1991). Cell adhesion molecules expression and modulation on human neuroblastoma cells.. PubMed. 366. 293–9. 9 indexed citations
15.
Beck, D, et al.. (1990). Monoclonal antibodies to gamma-interferon treated LAN-1 cells detect modulation of ganglioside GD2 exposure on human neuroblastoma cells.. PubMed. 9(6). 1519–24. 3 indexed citations
16.
Suardet, Laurent, et al.. (1989). Epidermal growth factor responsiveness of a new human neuroblastoma cell line. International Journal of Cancer. 44(4). 661–668. 17 indexed citations
17.
Beck, D, M Favrot, Christiane Bailly, et al.. (1988). Immunocytochemical detection of neuroblastoma cells infiltrating clinical bone marrow samples. European Journal of Pediatrics. 147(6). 609–612. 26 indexed citations
18.
Beck, D, et al.. (1987). In vitro antigenic modulation of human neuroblastoma cells induced by ifn‐γ, retinoic acid and dibutyryl cyclic amp. International Journal of Cancer. 39(4). 521–529. 39 indexed citations
19.
Beck, D, et al.. (1986). Highly selective recognition of human neuroblastoma cells by mouse monoclonal antibody to a cytoplasmic antigen.. PubMed. 46(6). 2988–94. 16 indexed citations
20.
Beck, D, et al.. (1983). Synthesis of antigens, cross-reactive with bovine serum albumin, by cultured neuroblastoma cells.. PubMed. 43(2). 858–63. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026